Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Clinical Medicine of China ; (12): 317-322, 2021.
Article in Chinese | WPRIM | ID: wpr-909750

ABSTRACT

Bladder cancer is one of the most common malignant tumors in the urinary system, and the current standard treatment for muscle-invasive bladder cancer(MIBC) is radical cystectomy combined with pelvic lymphadenectomy.However, radical cystectomy is a surgical method with serious damege and high incidence of perioperative complications, leading to a low postoperative quality of life for patients.In recent years, with the improvement of chemotherapy regimens and the development of radiotherapy techniques, bladder preservation comprehensive therapy based on partial cystectomy(PC) has attracted the attention of domestic and foreign scholars again.This article reviews the current application and treatment progress of PC.

2.
Chinese Journal of Radiological Medicine and Protection ; (12): 192-196, 2018.
Article in Chinese | WPRIM | ID: wpr-708039

ABSTRACT

Objective To compare the efficacy of trimodality therapy and chemoradiation therapy (CRT) alone in patients with locally advanced resectable esophageal squamous cell carcinoma (SCC).Methods A total of 124 cases with locally advanced resectable esophageal SCC were retrospectively analyzed and classified into 2 groups.Fifty-four cases in trimodality group were treated with surgery and preoperative chemoradiation,while 70 cases in CRT alone group only received radiation and chemotherapy.Local tumor control,3-year survival and treatment-related mortality were assessed.Results The local recurrent rate of the resected patients was 18.5% in trimodality group and 35.7% in CRT alone group,respectively(x2 =4.445,P < 0.05).The 3-year progression-free survival (PFS) was 65.3% (95% CI 50.7-80.5) in trimodality group and31.9% (95%CI 19.6-44.2) in CRT alone group (P<0.05),while the overall survival (OS) 66.3% (95% CI43.0-89.6) and 34.4% (95% CI 21.1-47.7),respectively(P < 0.05).Treatment-related mortality was 1.9% in trimodality group and 2.9% in CRT alone group (P > 0.05).For CRT alone group,the sub-group analysis showed that there was no statistically significant difference in the 3-year OS between patients who received 50-50.4 Gy and those who received the dose over 50.4 Gy (39.9% 95% CI 18.5-61.3 vs.31.5% 95% CI 14.8-48.2,P >0.05).Conclusions Compared with CRT alone,trimodality therapy showed the superior local control,PFS and OS,with similar treatment-related mortality in the treatment of patients with SCC of esophagus.The role of surgery could not be replaced by CRT alone even with the augment of radiation dose.

3.
Cancer Research and Treatment ; : 259-265, 2016.
Article in English | WPRIM | ID: wpr-64181

ABSTRACT

PURPOSE: Adjuvant chemoradiation following primary surgery is frequently indicated in patients with stage IB cervical cancer. The aim of this study is to evaluate the role of a magnetic resonance imaging (MRI)-based strategy in avoiding trimodality therapy. MATERIALS AND METHODS: We retrospectively reviewed all patients with stage IB cervical cancer treated initially with primary surgery at Seoul National University Hospital. We suggest an alternative triage strategy in which the primary treatment modality is determined based on preoperative MRI findings. Using this strategy, primary surgery is only indicated when there is no evidence of parametrial involvement (PMI) and lymph node metastasis (LNM) in the MRI results; when there is evidence of either or both of these factors, primary chemoradiation is selected. Assuming that this strategy is applied to our cohort, we evaluate how the rate of trimodality therapy is affected. RESULTS: Of the 254 patients in our sample, 77 (30.3%) had at least one category 1 risk factor (PMI, LNM, positive resection margin) upon pathologic examination. If the MRI-based strategy had been applied to our cohort, 168 patients would have undergone primary surgery and 86 would have undergone primary chemoradiation. Only 25 patients (9.8%) would have required trimodality therapy based on an indication of at least one category 1 pathologic risk factor following radical hysterectomy. CONCLUSION: The inclusion of MRI in the decision-making process for primary treatment modality could have reduced the number of patients requiring trimodality therapy based on the indication of a category 1 risk factor from 30.3% to 9.8% in our cohort.


Subject(s)
Humans , Chemoradiotherapy , Cohort Studies , Hysterectomy , Lymph Nodes , Magnetic Resonance Imaging , Neoplasm Metastasis , Retrospective Studies , Risk Factors , Seoul , Triage , Uterine Cervical Neoplasms
SELECTION OF CITATIONS
SEARCH DETAIL